PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 175 filers reported holding PRECIGEN INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $918,137 | +34.6% | 646,575 | +9.0% | 0.37% | +24.1% |
| Q2 2023 | $681,921 | +8.5% | 592,975 | 0.0% | 0.30% | -3.9% |
| Q1 2023 | $628,554 | +69661.8% | 592,975 | 0.0% | 0.31% | -29.5% |
| Q4 2022 | $901 | -99.9% | 592,975 | +1.1% | 0.44% | -29.7% |
| Q3 2022 | $1,243,000 | +58.1% | 586,401 | 0.0% | 0.63% | +71.8% |
| Q2 2022 | $786,000 | -36.7% | 586,401 | -0.3% | 0.36% | -27.1% |
| Q1 2022 | $1,241,000 | -41.7% | 587,964 | +2.6% | 0.50% | -39.1% |
| Q4 2021 | $2,127,000 | -26.1% | 573,304 | -0.6% | 0.82% | -21.5% |
| Q3 2021 | $2,879,000 | -23.5% | 576,970 | 0.0% | 1.05% | -25.2% |
| Q2 2021 | $3,762,000 | -5.4% | 576,970 | 0.0% | 1.40% | -10.8% |
| Q1 2021 | $3,975,000 | -18.3% | 576,970 | +21.0% | 1.57% | -28.5% |
| Q4 2020 | $4,865,000 | +186.9% | 476,970 | -1.6% | 2.20% | +115.3% |
| Q3 2020 | $1,696,000 | -29.9% | 484,540 | 0.0% | 1.02% | -27.9% |
| Q2 2020 | $2,418,000 | +19.0% | 484,540 | -18.9% | 1.42% | +11.1% |
| Q1 2020 | $2,032,000 | – | 597,740 | – | 1.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |